Latest Breaking News On - Purdue institute for drug discovery - Page 7 : comparemela.com

Amplified Sciences receives $400,000 NCI grant to improve early detection of pancreatic cancer

Amplified Sciences receives $400,000 NCI grant to improve early detection of pancreatic cancer
purdue.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from purdue.edu Daily Mail and Mail on Sunday newspapers.

West lafayetteUnited statesPurdue universityDiana caldwellSteve martinMitchelle daniels jrV jo davissonJo davissonAssociation of publicPurdue university college of pharmacyPhasei small business innovation researchPurdue research foundation office of technology commercializationPurdue institute for drug discoveryNational cancer instituteSchool of businessPurdue research foundation

Amplified Sciences receives $400,000 NCI grant to improve early detection of pancreatic cancer

Purdue universityUnited statesWest lafayetteDiana caldwellSteve martinMitchelle daniels jrV jo davissonJo davissonUs servicesPhasei small business innovation researchIpwatchdog instituteNational cancer institutePurdue university college of pharmacyPurdue research foundationPurdue research foundation office of technology commercializationAssociation of public

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to remove them, by using a new diagnostic test currently in development.

United statesPurdue universityLily ramseyDiana caldwellV jo davissonPurdue institute for drug discoveryPhasei small business innovation researchPurdue research foundation office of technology commercializationNational institutes of healthNational cancer institutePurdue university college of pharmacyPurdue instituteNational institutesElevate venturesPurdue research foundation officePancreatic cancer

UK study: new drug shows promise against Toxoplasmosis

Findings from a new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry May 28 may lead to a new treatment against Toxoplasma gondii, the parasite that causes toxoplasmosis. The labs of Matthew Gentry, Ph.D., and Craig Vander Kooi, Ph.D., in the Department of Molecular and Cellular Biochemistry, Anthony Sinai, Ph.D., in the Department of Microbiology, Immunology and Molecular Genetics, and Zhong-Yin Zhang, Ph.D., at the Purdue Institute for Drug Discovery, collaborated to develop a drug that targets the cyst form of the parasite. Dr. Greg talks with Gentry about the breakthrough research.

United kingdomVander kooiRobert murphyCraig vander kooiJianping linTiantian chenCenters for diseaseDepartment of microbiologyPurdue institute for drug discoveryNational institute of allergyNational institutes of healthDepartment of molecularNational institute of neurological disordersFrom united kingdom nowDisease controlMatthew gentry

UK Study: New Drug Shows Promise Against Toxoplasmosis

Those who have severe toxoplasmosis can harbor a cyst version of the parasite within brain and muscle tissue. These cysts are responsible for causing serious disease, especially in people who are immunocompromised.

Vander kooiRobert murphyCraig vander kooiJianping linTiantian chenCenters for diseaseDepartment of microbiologyUniversity of kentucky college medicinePurdue institute for drug discoveryDepartment of molecularKentucky collegeBiological chemistry mayDisease controlMatthew gentryCellular biochemistryAnthony sinai